Protective effect of ambroxol against paraquat-induced pulmonary fibrosis in rats

Internal Medicine

Volumn 50, Issue 18, 2011, Pages 1879-1887

  Zhi, Qiao Ming ^a   Yang, Li Tao ^b   Sun, Hai Chen ^a  

^a NANJING UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Ambroxol; Intoxication; Lung; Paraquat; Pulmonary fibrosis

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; AMBROXOL; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GELATINASE A; GLUTATHIONE PEROXIDASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PARAQUAT; SUPEROXIDE DISMUTASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL INFILTRATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HISTOLOGY; INFLAMMATORY CELL; LUNG EDEMA; LUNG FIBROSIS; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; UPREGULATION;

AMBROXOL; ANIMALS; COLLAGEN; CYTOKINES; DISEASE MODELS, ANIMAL; EXPECTORANTS; LUNG; MALE; OXIDATIVE STRESS; PARAQUAT; PULMONARY FIBROSIS; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 80052826054     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.5407     Document Type: Article

References (28)

1. Naito H, Yamashita M. Epidemiology of paraquat in Japan and a new safe formulation of paraquat. Hum Toxicol 6: 87-88, 1987.
2. Tang WJ, Sun HC, Xu BH, et al. Emergency treatment of acute paraquat intoxication. J Med Postgrad 21: 394-397, 2008 (in Chinese).
3. van der Wal NA, van Oirschot JF, van Dijk A, et al. Mechanism of protection of alveolar type II cells against paraquat-induced cytotoxicity by deferoxamine. Biochem Pharmacol 39: 1665-1671, 1990.
4. Hemmati AA, Nazari Z, Motlagh ME, Goldasteh S. The role of sodium cromolyn in treatment of paraquat-induced pulmonary fibrosis in rat. Pharmacol Res 46: 229-234, 2002.
5. Suntres ZE. Role of antioxidants in paraquat toxicity. Toxicology 180: 65-77, 2002.
6. Ishida Y, Takayasu T, Kimura A, et al. Gene expression of cytokines and growth factors in the lungs after paraquat administration in mice. Leg Med (Tokyo) 8: 102-109, 2006.
7. Satomi Y, Tsuchiya W, Miura D, Kasahara Y, Akahori F. DNA microarray analysis of pulmonary fibrosis three months after exposure to paraquat in rats. J Toxicol Sci 31: 345-355, 2006.
8. Malerba M, Ragnoli B. Ambroxol in the 21st century: pharmacological and clinical update. Expert Opin Drug Metab Toxicol 4: 1119-1129, 2008.
9. Nowak D, Antczak A, Krol M, et al. Antioxidant properties of Ambroxol. Free Radic Biol Med 16: 517-522, 1994.
10. Beeh KM, Beier J, Esperester A, et al. Antiinflammatory properties of ambroxol. Eur J Med Res 13: 557-562, 2008.
11. Piotrowski WJ, Pietras T, Kurmanowska Z, et al. Effect of paraquat intoxication and ambroxol treatment on hydrogen peroxide production and lipid peroxidation in selected organs of rat. J Appl Toxicol 16: 501-507, 1996.
12. Stockley RA, Shaw J, Burnett D. Effect of ambroxol of neutrophil chemotaxis in vitro. Agents Actions 24: 292-296, 1988.
13. Perin L, Donnini M, Diomede L, et al. Protection against acute paraquat toxicity by ambroxol. Cytotechnology 5: S25-S27, 1991.
14. Salmona M, Donnini M, Perin L, et al. A novel pharmacological approach for paraquat poisoning in rat and A549 cell line using ambroxol, a lung surfactant synthesis inducer. Food Chem Toxicol 30: 789-794, 1992.
15. Ashcroft T, Simpson JD, Timbrell V, et al. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 41: 467-470, 1988.
16. Strausz J, Muller-Quernheim J, Steppling H, et al. Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis. Am Rev Respir Dis 141: 124-128, 1990.
17. Wang GY, Hirai K, Shimada H. Mitochondrial breakage induced by the herbicide paraquat in cultured human lung cells. J Electron Microsc (Tokyo) 41: 181-184, 1992.
18. Harris ED. Regulation of antioxidant enzymes. FASEB J 6: 2675-2683, 1992.
19. Melchiorri D, Reiter RJ, Sewerynek E, et al. Paraquat toxicity and oxidative damage. Reduction by melatonin. Biochem Pharmacol 51: 1095-1099, 1996.
20. Ghazi-Khansari M, Mohammadi-Karakani A, Sotoudeh M, et al. Antifibrotic effect of captopril and enalapril on paraquat-induced lung fibrosis in rats. J Appl Toxicol 27: 342-349, 2007.
21. Schultz J, Kaminker K. Myeloperoxidase of the leucocyte of normal human blood. I. Content and localization. Arch Biochem Biophys 96: 465-467, 1962.
22. Dinis-Oliveira RJ, Sousa C, Remiao F, et al. Full survival of paraquat-exposed rats after treatment with sodium salicylate. Free Radic Biol Med 42: 1017-1028, 2007.
23. Kienast K, Knorst M, Muller-Quernheim J, et al. Modulation of IL-1 beta, IL-6, IL-8, TNF-alpha, and TGF-beta secretions by alveolar macrophages under NO2 exposure. Lung 174: 57-67, 1996.
24. Corbel M, Theret N, Caulet-Maugendre S, et al. Repeated endotoxin exposure induces interstitial fibrosis associated with enhanced gelatinase (MMP-2 and MMP-9) activity. Inflamm Res 50: 129-135, 2001.
25. Corbel M, Caulet-Maugendre S, Germain N, et al. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat. J Pathol 193: 538-545, 2001.
26. Rahman I, MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic Biol Med 28: 1405-1420, 2000.
27. Rahman I. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. J Biochem Mol Biol 36: 95-109, 2003.
28. Ma YT, Tian YP, Su JL, et al. Influence of ambroxol on paraquatinduced lung tissue injury and change of pulmonary surfactantassociated protein A in the experimental rats. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 24: 348-351, 2006 (in Chinese).